HAEMONETICS CORP — Director's Dealing 2020

Aug 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2020-08-11

Reporting Person: ABERNATHY ROBERT E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-11	Common Stock	P	4000	$80.93	Acquired	12048	Direct

Footnotes

F1: This number includes unvested restricted stock units previously reported.